{"count": 26, "results": [{"_id": "33808460", "pmid": 33808460, "pmcid": "PMC8065978", "title": "Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review", "journal": "J Pers Med", "authors": ["Stanescu AMA", "Simionescu AA", "Florea M", "Diaconu CC"], "date": "2021-03-30T00:00:00Z", "doi": "10.3390/jpm11040251", "meta_date_publication": "2021 Mar 30", "meta_volume": "11", "meta_issue": "4", "meta_pages": "", "score": 50283.176, "text_hl": "Is @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ a Possible Beneficial Treatment for @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@Psoriasis@@@? ", "citations": {"NLM": "Stanescu AMA, Simionescu AA, Florea M, Diaconu CC. Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review J Pers Med. 2021 Mar 30;11(4):. PMID: 33808460", "BibTeX": "@article{33808460, title={Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review}, author={Stanescu AMA and Simionescu AA and Florea M and Diaconu CC}, journal={J Pers Med}, volume={11}, number={4}}"}}, {"_id": "38028405", "pmid": 38028405, "pmcid": "PMC10646712", "title": "The efficacy of metformin for the treatment of psoriasis: a meta-analysis study", "journal": "Postepy Dermatol Alergol", "authors": ["Huang Z", "Li J", "Chen H", "Yu D", "Sun S"], "date": "2023-10-01T00:00:00Z", "doi": "10.5114/ada.2023.130524", "meta_date_publication": "2023 Oct", "meta_volume": "40", "meta_issue": "5", "meta_pages": "606-610", "score": 50273.87, "text_hl": "The efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for the treatment of @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@: a meta-analysis study", "citations": {"NLM": "Huang Z, Li J, Chen H, Yu D, Sun S. The efficacy of metformin for the treatment of psoriasis: a meta-analysis study Postepy Dermatol Alergol. 2023 Oct;40(5):606-610. PMID: 38028405", "BibTeX": "@article{38028405, title={The efficacy of metformin for the treatment of psoriasis: a meta-analysis study}, author={Huang Z and Li J and Chen H and Yu D and Sun S}, journal={Postepy Dermatol Alergol}, volume={40}, number={5}, pages={606-610}}"}}, {"_id": "35492738", "pmid": 35492738, "pmcid": "PMC9054475", "title": "The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome", "journal": "Dermatol Res Pract", "authors": ["Tam HTX", "Thuy LND", "Vinh NM", "Anh TN", "Van BT"], "date": "2022-04-22T00:00:00Z", "doi": "10.1155/2022/9838867", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "9838867", "score": 50268.316, "text_hl": "The Combined Use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @CHEMICAL_Methotrexate @CHEMICAL_MESH:D008727 @@@Methotrexate@@@ in @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@Psoriasis@@@ @SPECIES_9606 @@@Patients@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@Metabolic Syndrome@@@", "citations": {"NLM": "Tam HTX, Thuy LND, Vinh NM, Anh TN, Van BT. The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome Dermatol Res Pract. 2022;2022():9838867. PMID: 35492738", "BibTeX": "@article{35492738, title={The Combined Use of Metformin and Methotrexate in Psoriasis Patients with Metabolic Syndrome}, author={Tam HTX and Thuy LND and Vinh NM and Anh TN and Van BT}, journal={Dermatol Res Pract}, volume={2022}, pages={9838867}}"}}, {"_id": "35569426", "pmid": 35569426, "pmcid": "PMC9111182", "title": "Metformina en el tratamiento de enfermedades dermatologicas: una revision narrativa", "journal": "Aten Primaria", "authors": ["Monte-Serrano J", "Villagrasa-Boli P", "Cruañes-Monferrer J", "Arbués-Espinosa P", "Martínez-Cisneros S", "García-Gil MF"], "date": "2022-06-01T00:00:00Z", "doi": "10.1016/j.aprim.2022.102354", "meta_date_publication": "2022 Jun", "meta_volume": "54", "meta_issue": "6", "meta_pages": "102354", "score": 50265.844, "text_hl": "...La @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformina@@@ activa la proteincinasa mediada por AMP (@GENE_PRKAA1 @GENE_5562 @@@AMPK@@@), la cual disminuye la actividad de las celulas dendriticas cutaneas, linfocitos T, macrofagos, celulas endoteliales y monocitos, todos ellos implicados en la patogenesis de la @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@. ", "citations": {"NLM": "Monte-Serrano J, Villagrasa-Boli P, Cruañes-Monferrer J, Arbués-Espinosa P, Martínez-Cisneros S, García-Gil MF. Metformina en el tratamiento de enfermedades dermatologicas: una revision narrativa Aten Primaria. 2022 Jun;54(6):102354. PMID: 35569426", "BibTeX": "@article{35569426, title={Metformina en el tratamiento de enfermedades dermatologicas: una revision narrativa}, author={Monte-Serrano J and Villagrasa-Boli P and Cruañes-Monferrer J and Arbués-Espinosa P and Martínez-Cisneros S and García-Gil MF}, journal={Aten Primaria}, volume={54}, number={6}, pages={102354}}"}}, {"_id": "35266419", "pmid": 35266419, "title": "Co-encapsulation of metformin and ginger into the liposomes: in vitro characterization and in vivo anti-psoriasis evaluation.", "journal": "Drug Dev Ind Pharm", "authors": ["Jenabikordi K", "Zadeh BSM", "Rezaie A"], "date": "2021-09-01T00:00:00Z", "doi": "10.1080/03639045.2021.2001488", "meta_date_publication": "2021 Sep", "meta_volume": "47", "meta_issue": "9", "meta_pages": "1447-1458", "score": 50261.73, "text_hl": "Co-encapsulation of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and ginger into the liposomes: in vitro characterization and in vivo anti-@<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@ evaluation.", "citations": {"NLM": "Jenabikordi K, Zadeh BSM, Rezaie A. Co-encapsulation of metformin and ginger into the liposomes: in vitro characterization and in vivo anti-psoriasis evaluation. Drug Dev Ind Pharm. 2021 Sep;47(9):1447-1458. PMID: 35266419", "BibTeX": "@article{35266419, title={Co-encapsulation of metformin and ginger into the liposomes: in vitro characterization and in vivo anti-psoriasis evaluation.}, author={Jenabikordi K and Zadeh BSM and Rezaie A}, journal={Drug Dev Ind Pharm}, volume={47}, number={9}, pages={1447-1458}}"}}, {"_id": "32845585", "pmid": 32845585, "title": "Oral Metformin for Treating Dermatological Diseases: A Systematic Review.", "journal": "J Drugs Dermatol", "authors": ["Sung CT", "Chao T", "Lee A", "Foulad DP", "Choi F", "Juhasz M", "Dobry A", "Mesinkovska NA"], "date": "2020-08-01T00:00:00Z", "doi": "10.36849/JDD.2020.4874", "meta_date_publication": "2020 Aug 1", "meta_volume": "19", "meta_issue": "8", "meta_pages": "713-720", "score": 50259.977, "text_hl": "@SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ experienced quantifiable clinical responses. ", "citations": {"NLM": "Sung CT, Chao T, Lee A, Foulad DP, Choi F, Juhasz M, Dobry A, Mesinkovska NA. Oral Metformin for Treating Dermatological Diseases: A Systematic Review. J Drugs Dermatol. 2020 Aug 1;19(8):713-720. PMID: 32845585", "BibTeX": "@article{32845585, title={Oral Metformin for Treating Dermatological Diseases: A Systematic Review.}, author={Sung CT and Chao T and Lee A and Foulad DP and Choi F and Juhasz M and Dobry A and Mesinkovska NA}, journal={J Drugs Dermatol}, volume={19}, number={8}, pages={713-720}}"}}, {"_id": "35910506", "pmid": 35910506, "pmcid": "PMC9326038", "title": "Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation", "journal": "Clin Cosmet Investig Dermatol", "authors": ["Zhang L", "Liu X", "Huang M", "Wang R", "Zhu W", "Li Y", "Shen L", "Li C"], "date": "2022-07-22T00:00:00Z", "doi": "10.2147/CCID.S368845", "meta_date_publication": "2022", "meta_volume": "15", "meta_issue": "", "meta_pages": "1403-1413", "score": 50257.96, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@) has been proved to be effective for the treatment of @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@. ", "citations": {"NLM": "Zhang L, Liu X, Huang M, Wang R, Zhu W, Li Y, Shen L, Li C. Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation Clin Cosmet Investig Dermatol. 2022;15():1403-1413. PMID: 35910506", "BibTeX": "@article{35910506, title={Metformin Inhibits HaCaT Cell Proliferation Under Hyperlipidemia Through Reducing Reactive Oxygen Species via FOXO3 Activation}, author={Zhang L and Liu X and Huang M and Wang R and Zhu W and Li Y and Shen L and Li C}, journal={Clin Cosmet Investig Dermatol}, volume={15}, pages={1403-1413}}"}}, {"_id": "34884312", "pmid": 34884312, "pmcid": "PMC8658299", "title": "The Antidiabetic Agent Metformin Inhibits IL-23 Production in Murine Bone-Marrow-Derived Dendritic Cells", "journal": "J Clin Med", "authors": ["Matsuda-Taniguchi T", "Takemura M", "Nakahara T", "Hashimoto-Hachiya A", "Takai-Yumine A", "Furue M", "Tsuji G"], "date": "2021-11-29T00:00:00Z", "doi": "10.3390/jcm10235610", "meta_date_publication": "2021 Nov 29", "meta_volume": "10", "meta_issue": "23", "meta_pages": "", "score": 50255.336, "text_hl": "In addition, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration has been shown to improve the severity of @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@. ", "citations": {"NLM": "Matsuda-Taniguchi T, Takemura M, Nakahara T, Hashimoto-Hachiya A, Takai-Yumine A, Furue M, Tsuji G. The Antidiabetic Agent Metformin Inhibits IL-23 Production in Murine Bone-Marrow-Derived Dendritic Cells J Clin Med. 2021 Nov 29;10(23):. PMID: 34884312", "BibTeX": "@article{34884312, title={The Antidiabetic Agent Metformin Inhibits IL-23 Production in Murine Bone-Marrow-Derived Dendritic Cells}, author={Matsuda-Taniguchi T and Takemura M and Nakahara T and Hashimoto-Hachiya A and Takai-Yumine A and Furue M and Tsuji G}, journal={J Clin Med}, volume={10}, number={23}}"}}, {"_id": "37820943", "pmid": 37820943, "title": "Design, synthesis and characterization of a novel multicomponent salt of bexarotene with metformin and application in ameliorating psoriasis with T2DM.", "journal": "Int J Pharm", "authors": ["Yang Y", "Yu M", "Ren L", "An Q", "Li W", "Yang H", "Zhang Y", "Zhang S", "Hao Y", "Du G", "Yang D", "Lu Y", "Wang J"], "date": "2023-11-05T00:00:00Z", "doi": "10.1016/j.ijpharm.2023.123501", "meta_date_publication": "2023 Nov 5", "meta_volume": "646", "meta_issue": "", "meta_pages": "123501", "score": 50254.7, "text_hl": "Design, synthesis and characterization of a novel multicomponent @CHEMICAL_Salts @CHEMICAL_MESH:D012492 @@@salt@@@ of @CHEMICAL_Bexarotene @CHEMICAL_MESH:D000077610 @@@bexarotene@@@ with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and application in ameliorating @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@.", "citations": {"NLM": "Yang Y, Yu M, Ren L, An Q, Li W, Yang H, Zhang Y, Zhang S, Hao Y, Du G, Yang D, Lu Y, Wang J. Design, synthesis and characterization of a novel multicomponent salt of bexarotene with metformin and application in ameliorating psoriasis with T2DM. Int J Pharm. 2023 Nov 5;646():123501. PMID: 37820943", "BibTeX": "@article{37820943, title={Design, synthesis and characterization of a novel multicomponent salt of bexarotene with metformin and application in ameliorating psoriasis with T2DM.}, author={Yang Y and Yu M and Ren L and An Q and Li W and Yang H and Zhang Y and Zhang S and Hao Y and Du G and Yang D and Lu Y and Wang J}, journal={Int J Pharm}, volume={646}, pages={123501}}"}}, {"_id": "32194991", "pmid": 32194991, "pmcid": "PMC7055596", "title": "Metformin inhibits IL-1beta secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis", "journal": "Cell Death Discov", "authors": ["Tsuji G", "Hashimoto-Hachiya A", "Yen VH", "Takemura M", "Yumine A", "Furue K", "Furue M", "Nakahara T"], "date": "2020-03-04T00:00:00Z", "doi": "10.1038/s41420-020-0245-8", "meta_date_publication": "2020", "meta_volume": "6", "meta_issue": "", "meta_pages": "11", "score": 50254.21, "text_hl": "These results indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration prevented @<m>DISEASE_Psoriasis</m> @DISEASE_MESH:D011565 @@@psoriasis@@@ development in vivo. ", "citations": {"NLM": "Tsuji G, Hashimoto-Hachiya A, Yen VH, Takemura M, Yumine A, Furue K, Furue M, Nakahara T. Metformin inhibits IL-1beta secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis Cell Death Discov. 2020;6():11. PMID: 32194991", "BibTeX": "@article{32194991, title={Metformin inhibits IL-1beta secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis}, author={Tsuji G and Hashimoto-Hachiya A and Yen VH and Takemura M and Yumine A and Furue K and Furue M and Nakahara T}, journal={Cell Death Discov}, volume={6}, pages={11}}"}}]}